Wolverine
Wolverine blend · BPC-157/TB-500
Wolverine is a research blend combining two repair peptides — BPC-157 (5 mg) and TB-500 (5 mg). Both are documented in vitro for angiogenesis, cell migration and growth-factor modulation. Reagent intended exclusively for laboratory research — not intended for human consumption.
Key facts
- Composition
- BPC-157 5 mg + TB-500 5 mg
- Type
- 2-peptide blend
- Form
- Lyophilised (powder)
- Status
- Research Use Only
Study library
All results on PubMedIntra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.
Lee E, et al. · Alternative therapies in health and medicine · 2021
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, et al. · Sports medicine (Auckland, N.Z.) · 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
Tewari K, et al. · The American journal of sports medicine · 2026
Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500.
Tham A, et al. · The Journal of the American Academy of Orthopaedic Surgeons · 2026
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
Biçer O, et al. · Joint diseases and related surgery · 2026
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Luansritisakul C, et al. · Current pain and headache reports · 2026
Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.
Mazza AD · Integrative medicine (Encinitas, Calif.) · 2026
Results retrieved live from PubMed (NCBI). Research literature only — no medical advice.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease